| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2000) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | N03AX15 |
| UNII: | 459384H98V |
Structure
| InChI Key | UBQNRHZMVUUOMG-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C8H8N2O3S |
| Molecular Weight | 212.23 |
| AlogP | 1.85 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 87.18 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 14.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BLOCKER | Sodium channel alpha subunit blocker |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 0.5472 | |
|
Enzyme
Lyase
|
- | 1860 | 20.6 | 10.3-6800 | - | |
|
Enzyme
Oxidoreductase
|
- | 24800 | - | 3100-30800 | - | |
|
Enzyme
Transferase
|
- | - | - | - | 7.575-10.77 | |
|
Enzyme
|
- | 1860 | 20.6 | 10.3-6800 | 7.575-10.77 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -14.18--4.77 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Seizures | 4 | D012640 | ClinicalTrials |
| Alcoholism | 3 | D000437 | ClinicalTrials |
| Schizophrenia | 3 | D012559 | ClinicalTrials |
| Weight Gain | 3 | D015430 | ClinicalTrials |
| Psychotic Disorders | 3 | D011618 | ClinicalTrials |
| Epilepsy, Complex Partial | 3 | D017029 | ClinicalTrials |
| Feeding and Eating Disorders | 3 | D001068 | ClinicalTrials |
| Alcoholism | 3 | D000437 | ClinicalTrials |
| Migraine Disorders | 3 | D008881 | ClinicalTrials |
| Smoking Cessation | 3 | D016540 | ClinicalTrials |
| Obesity | 2 | D009765 | ClinicalTrials |
| Hearing Loss | 2 | D034381 | ClinicalTrials |
| Parkinson Disease | 2 | D010300 | ClinicalTrials |
| Essential Tremor | 2 | D020329 | ClinicalTrials |
| Tobacco Use Disorder | 1 | D014029 | ClinicalTrials |
| Cocaine-Related Disorders | 1 | D019970 | ClinicalTrials |
| Hearing Loss, Noise-Induced | 1 | D006317 | ClinicalTrials |
Side Effects from Label
Side Effects (PT)
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 68291-97-4 |
| ChEBI | 10127 |
| ChEMBL | CHEMBL750 |
| DrugBank | DB00909 |
| DrugCentral | 2872 |
| EPA CompTox | DTXSID9046023 |
| FDA SRS | 459384H98V |
| Human Metabolome Database | HMDB15045 |
| Guide to Pharmacology | 7047 |
| KEGG | C07504 |
| PDB | ZON |
| PharmGKB | PA451978 |
| PubChem | 11967800 |
| SureChEMBL | SCHEMBL35458 |
| ZINC | ZINC000000004321 |
CONTENTS